2 Dividend Stocks to Buy Hand Over Fist in November was originally published by The Motley Fool Their recent issues are ...

A long history of consistently increasing dividends is highly valued by Lynch. His guides are to look for companies with a track record of stable dividends for at least 20 years. Both ABBV and PFE ...

However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings. To qualify, a ...

Dividend yield and robust drug pipeline are bullish ... Data by YCharts Shares of AbbVie experienced one of their worst ...

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two ...

In the wake of the presidential election, another change in interest rates and continued news about geopolitical unrest, the appeal of blue-chip stocks is stronger than ever. That' ...

One of the best ways to build wealth is with dividend stocks – especially if they’re attached to solid companies with a ...

Dividend growth stocks offer a unique blend of reliability and growth potential, making them an ideal choice for long-term ...

Strategists at Wells Fargo Investment Institute see the fed funds rate dropping a total of one percentage point this year and ...

Dividend stocks are attractive for their steady income, stability, and growth potential, especially amid low interest rates ...

AbbVie stock drops after Phase 2 trials of emraclidine fail to meet primary endpoint. The company continues data analysis for ...

With a current dividend yield of 3.2%, AbbVie Inc. ABBV was a key stock in the investor’s portfolio earning $4,800 per month. The stock has gained about 44% over the past year. AbbVie has raised ...